Filed: 5/13/2025ACC: 0000950123-25-004952
📋 What this filing means
MWG MANAGEMENT LTD. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $58.69M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$58.69M
Total AUM (reported)
24.22M
Total Shares
Allocation by class
COM$58.69M100.0%
Portfolio Concentration
Top 3$58.69M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.22M
Sole
Full voting authority
24.22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other3
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BEAM THERAPEUTICS INC
DFNDShares2.27M
TypeSH
Market value$44.27M
75.44%
Sole
2.27M
Shared
0.00
None
0.00
LYELL IMMUNOPHARMA INC
DFNDShares20.16M
TypeSH
Market value$10.85M
18.48%
Sole
20.16M
Shared
0.00
None
0.00
PRIME MEDICINE INC
DFNDShares1.79M
TypeSH
Market value$3.57M
6.08%
Sole
1.79M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BEAM THERAPEUTICS INCDFND | COM | 2.27M | SH | $44.27M 75.44% | 2.27M | 0.00 | 0.00 |
LYELL IMMUNOPHARMA INCDFND | COM | 20.16M | SH | $10.85M 18.48% | 20.16M | 0.00 | 0.00 |
PRIME MEDICINE INCDFND | COM | 1.79M | SH | $3.57M 6.08% | 1.79M | 0.00 | 0.00 |